Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC
Clinical trial NCT03607539 · COMPLETED
Trial details
- NCT number
- NCT03607539
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-11-15
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.